Featured Research

from universities, journals, and other organizations

First U.S. implantation of fully resorbable antibacterial envelope for cardiac devices

Date:
August 7, 2013
Source:
Vanderbilt University Medical Center
Summary:
A new fully resorbable "envelope" that encloses implantable cardiac devices, such as pacemakers and internal cardioverter defibrillators (ICDs), has been used for the first time, helping prevent surgical site infections.

Vanderbilt Heart and Vascular Institute is the first medical center in the United States to use a new fully resorbable "envelope" that encloses implantable cardiac devices, such as pacemakers and internal cardioverter defibrillators (ICDs), and helps prevent surgical site infections.

The AIGISRx R Antibacterial Envelope from TYRX, Inc. received U.S. Food and Drug Administration clearance on May 20.

AIGISRx R Antibacterial Envelope is a fully bioresorbable, antibacterial pouch-like mesh envelope that holds cardiac rhythm devices securely in place when implanted in the body. The envelope contains the antimicrobial agents rifampin and minocycline, which are released locally into the tissue, to help reduce infections associated with cardiac implantable electronic devices (CIEDs).

"Over the last several decades, the number of cardiac device infections has risen significantly and out of proportion to the number of cardiac device implantations. With more than 500,000 CIED implantations annually in the U.S., it is critical that the infections associated with these types of procedures are avoided to help save lives and money," according to cardiologist Christopher Ellis, M.D., assistant professor of Medicine, who used the resorbable envelope for the first time on Aug. 7.

The CIED is placed below the collar bone in a pocket the physician creates underneath the skin. Once the device is placed inside the mesh envelope and implanted into the pocket, the antimicrobials are released and the envelope dissolves entirely within about nine weeks.

"The infection protection is still there. It's nice to know when I go back into the pocket several years from now, I won't even know it (AIGISRx R) was ever in there," Ellis said.

Research by Ellis and colleagues at Vanderbilt has shown that the AIGISRx Antibacterial Envelope significantly reduced device infections by nearly 90 percent in high-risk patients, compared to patients who did not receive the AIGISRx.

Nationally, patients with surgical site infections following CIED procedures spend additional time in the hospital and undergo repeat surgical procedures to treat the infection. These patients experience significant increases in morbidity and mortality, with one-year mortality rates of greater than 25 percent, and three-year mortality of up to 50 percent, depending on device type.

Cardiac device generators typically need to be replaced every five to eight years due to wear and tear, and each time the procedure is performed, the rate of infection increases exponentially, Ellis said. In addition, there are some patients who are at greater risk of infection due to diabetes, kidney disease and prior device infection.


Story Source:

The above story is based on materials provided by Vanderbilt University Medical Center. Note: Materials may be edited for content and length.


Cite This Page:

Vanderbilt University Medical Center. "First U.S. implantation of fully resorbable antibacterial envelope for cardiac devices." ScienceDaily. ScienceDaily, 7 August 2013. <www.sciencedaily.com/releases/2013/08/130807204629.htm>.
Vanderbilt University Medical Center. (2013, August 7). First U.S. implantation of fully resorbable antibacterial envelope for cardiac devices. ScienceDaily. Retrieved August 20, 2014 from www.sciencedaily.com/releases/2013/08/130807204629.htm
Vanderbilt University Medical Center. "First U.S. implantation of fully resorbable antibacterial envelope for cardiac devices." ScienceDaily. www.sciencedaily.com/releases/2013/08/130807204629.htm (accessed August 20, 2014).

Share This




More Health & Medicine News

Wednesday, August 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola-Hit Sierra Leone's Freetown a City on Edge

Ebola-Hit Sierra Leone's Freetown a City on Edge

AFP (Aug. 19, 2014) Residents of Sierra Leone's capital voice their fears as the Ebola virus sweeps through west Africa. Duration: 00:56 Video provided by AFP
Powered by NewsLook.com
101-Year-Old Working Man Has All The Advice You Need

101-Year-Old Working Man Has All The Advice You Need

Newsy (Aug. 19, 2014) Herman Goldman has worked at the same lighting store for almost 75 years. Find out his secrets to a happy, productive life. Video provided by Newsy
Powered by NewsLook.com
Researcher Testing on-Field Concussion Scanners

Researcher Testing on-Field Concussion Scanners

AP (Aug. 19, 2014) Four Texas high school football programs are trying out an experimental system designed to diagnose concussions on the field. The technology is in response to growing concern over head trauma in America's most watched sport. (Aug. 19) Video provided by AP
Powered by NewsLook.com
American Ebola Patient Apparently Improving, Outbreak Is Not

American Ebola Patient Apparently Improving, Outbreak Is Not

Newsy (Aug. 19, 2014) Nancy Writebol, an American missionary who contracted Ebola, is apparently getting better, according to her husband. The outbreak, however, is not. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins